Stay updated on Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision v3.5.0 has been added. The previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:03:27.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:07:15.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is now listed under Resources. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T03:59:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the notice about lapse in government funding and the older Revision: v3.4.1 banner.
    Difference
    0.5%
    Check dated 2026-02-11T01:18:31.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a government funding status notice banner and updated the site revision from v3.4.0 to v3.4.1. The study details and related information remain unchanged.
    Difference
    0.5%
    Check dated 2026-02-04T00:31:08.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The page now displays a glossary and adds QC metadata (Last Update Submitted that Met QC Criteria), No FEAR Act Data, and Revision: v3.4.0. The previously shown items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:07.000Z thumbnail image

Stay in the know with updates to Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.